Saad Khanani advises public and private companies and venture capital and private equity firms in the technology, life sciences, and other growth industries.

Mr. Khanani helps public and private technology and life sciences companies, as well as institutional investors navigate a range of corporate transactions, including mergers and acquisitions and investments. He also advises emerging and growth companies on formation, corporate governance, securities law, and transactional matters.

Mr. Khanani guides clients through complex transactions and growth initiatives with business-oriented advice. He draws upon his prior experience as the founder of an apparel business and a management consultant at McKinsey & Company — where he advised senior leadership at technology companies and federal government agencies.

Mr. Khanani previously worked in Latham’s office in the United Arab Emirates with a practice focused on general corporate and technology transactions matters. In addition to his commercial work, Mr. Khanani maintains a pro bono practice, and is an active contributor to Latham’s training and development, recruiting, and diversity programs.

Mr. Khanani was a James Kent Scholar and a Harlan Fiske Stone Scholar and member of the Columbia Business Law Review and the Faculty Rules Committee while attending Columbia University School of Law.

Mergers & Acquisitions

Mr. Khanani’s public and private mergers and acquisitions and strategic transaction practice has included advising:


  • Apex Technology Acquisition Corporation in its pending US$2 billion acquisition of AvePoint
  • Block in its acquisitions of:
    • Verse Technologies
    • Dessa
    • Eloquent Labs
  • Bridgepoint Advisors in its acquisition of Calypso Technology
  • Cloudways in its US$350 million acquisition by DigitalOcean
  • Duolingo in its acquisition of Gunner
  • Evernote in its acquisition by Bending Spoons
  • Extreme Networks in its US$272 million acquisition of Aerohive Networks
  • Hightower in its strategic combination with VTS
  • Integrated Device Technology in its US$250 million acquisition of GigPeak
  • IXYS in its US$750 million sale to Littelfuse
  • Joby Aviation in its US$5 billion business combination with Reinvent Technology Partners
  • Mint Mobile in its pending US$1.35 billion acquisition by T-Mobile
  • Mellanox Technologies in its US$6.9 billion sale to NVIDIA Corporation
  • Meta in its strategic acquisitions of BigBox VR, Giphy, GrokStyle, Kustomer, Within, and other technology companies
  • NVIDIA in its potential US$40 billion acquisition of Arm, acquisition of Bright Computing, acquisition of DeepMap, and acquisition of Oski
  • Plaid in its acquisition of Cognito
  • Planet Labs in its US$2.8 billion business combination with dMY Technology Group IV
  • Postmates in its US$2.65 billion sale to Uber
  • Savvy Gaming Group in its pending US$4.9 billion acquisition of Scopely
  • SRS Acquiom in its sale to Lovell Minnick Partners
  • Vacasa, a Silver Lake portfolio company, in its acquisition of TurnKey Vacation Rentals

Healthcare and Life Sciences

  • Alliance HealthCare Services in connection with the acquisition by Tahoe Investment Group
  • Encore Vision in its US$465 million acquisition by Novartis AG
  • eResearchTechnology in its sale to Nordic Capital
  • Landmark Health in its sale to General Atlantic
  • Menlo Therapeutics in its US$390.5 million acquisition of Foamix Pharmaceuticals
  • Relypsa in its US$1.5 billion sale to Galenica AG
  • Revolution Medicines in its acquisition of Warp Drive Bio and other strategic transactions
  • Upside Foods in its acquisition of Cultured Decadence

Venture Capital

Mr. Khanani regularly represents venture capital and private equity firms in connection with private and public investments, acquisitions, and divestitures. His clients include:

  • 8VC
  • Andreessen Horowitz
  • BRV Capital Management
  • Chimera
  • Dragoneer Investment Group
  • Goldman Sachs
  • GreatPoint Ventures
  • KKR
  • NVIDIA Ventures
  • Patient Square Capital
  • SoftBank
  • Tencent
  • VentureSouq

Emerging Companies and Public Company Representation

Mr. Khanani advises public companies in corporate governance matters and strategic investments and emerging and growth companies in formation, corporate governance, securities law, and transactional matters. His experience includes advising:

  • AMD
  • Block
  • BlueSprig Pediatrics
  • Calysta
  • CorneaGen
  • CrossoverHealth
  • EchoNous
  • Hazel Health
  • Meta
  • Plaid
  • Synack
  • Upside Foods

Bar Qualification

  • California


  • JD, Columbia University School of Law, 2008
  • BA in Economics, Yale University, 2002